CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 3,034 shares at $5.77 ($17,506)
- 4 Open-market sale Trachtenberg Eric sold 2,452 shares at $5.77 ($14,148)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,452 shares at $5.77 ($14,148)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 2,911 shares at $5.77 ($16,796)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,586 shares at $5.77 ($43,771)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Other acquisition Director acquired 1,687,709 shares (other)
- 4 Exercise or conversion Chief Scientific Officer acquired 9,500 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 47,000 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 27,500 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 22,666 shares (grant or award)
- 4 Grant or award Trachtenberg Eric acquired 22,666 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 27,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 76,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 22,666 shares (grant or award)
Page 8 of 15 · 288 filings